Table 5 Performance of the search strategy
Systematic review | Topic areas | Studies included (n) | Studies indexed in Pubmed (n) | Studies retrieved by the search strategy n (%) | Patient preferences and decision making domain n (%) | Health state utility values domain n (%) |
|---|---|---|---|---|---|---|
Initial test of the relative recall | ||||||
McLean 2012 [29] | Antithrombotic therapy | 50 | 49 (98%) | 48 (97.9) | 48 (97.9) | 3 (6.1) |
Peasgood 2010 [41] | Breast cancer | 50 | 44 (88%) | 36 (81.8) | 32 (72,73) | 34 (77,27) |
Morton 2010 [40] | Chronic kidney disease | 18 | 15 (83%) | 15 (100.0) | 15 (100.0) | 1 (6.7) |
Petrillo 2011 [42] | COPD | 11 | 11 (100%) | 10 (90.9) | 5 (45.4) | 9 (81.8) |
Brooker 2013 [39] | COPD | 12 | 12 (100%) | 11 (91.7) | 11(91.7) | 2 (16.7) |
Bremmer 2007 [38] | Prostate cancer | 21 | 20 (95%) | 19 (95.0) | 18(90.0) | 18 (90.0) |
Relative recall results RR*(95% CI) (n) | 162 | 151 (93%) | 92% (86.4-95.4) (139) | 85.4% (78.9-90.1) (129) | 44.4% (36.4-52.3) (67) | |
Re-test | ||||||
Shaw 2016 [57] | CV disease and daibetes | 14 | 13 (93%) | 11 (86,62) | 11 (86,62) | 0 (0.0) |
Smith 2015 [58] | Phyisical activity in joint replacement | 13 | 13 (100%) | 9 (69,23) | 9 (69,23) | 1 (7,69) |
Finlayson 2015 [59] | Metastatic cancer | 15 | 15 (100%) | 8 (53,3) | 8 (53,3) | 0 (0,0) |
Köberich 2015 [60] | Patient-centered nursing care | 12 | 12 (100%) | 11 (91,6) | 11 (91,6) | 0 (0,0) |
Loewen 2017 [62] | Antithrombotic therapy in atrial fibr. | 28 | 26 (93%) | 25 (96,15) | 25 (96,15) | 11 (42,3) |
Cowley 2016 [61] | Esophagogastric cancer | 2 | 2 (100%) | 0 (0) | 0 (0) | 0 (0) |
Brown 2017 [63] | Lung cancer | 27 | 27 (100%) | 23 (85,15) | 11 (40,74) | 20(74,07) |
Jeong 2016 [73] | Colorectal cancer | 57 | 56 (98%) | 53 (94,64) | 26 (46,42) | 51 (91,07) |
Carter 2015 [65] | Gastric cancer | 8 | 7 (87.5%) | 7 (100) | 3 (42,8) | 7 (100) |
Ward 2017 [64] | Brain trauma | 5 | 5 (100%) | 4 (80) | 4 (80) | 2 (40) |
Relative recall results RR*(95% CI) (n) | 181 | 176 (97%) | 85,8% (79.9-90.2) (151) | 61.4 (54.0-68.3) (108) | 52.3% (44.9-59.5) (92) | |
Total. Relative recall results RR*(95% CI) (n) | 343 | 327 (95%) | 88,7% (84.8-91.7) (290) | 72.5% (67.4-77.0) (237) | 48.6% (43.2-54.0) (159) | |